CNS Pharmaceuticals Inc (CNSP)

0.1129 0.00 (0.00%) USD  |  NASDAQ  |  Dec 27, 16:00
0.1101 0.00 (0.00%) After-Hours: 20:00
More

CNS Pharmaceuticals Research and Development Expense (Quarterly): 4.245M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for CNSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Ligand Pharmaceuticals Inc 5.675M
Cellectar Biosciences Inc 5.494M
Revance Therapeutics Inc 11.38M
Zymeworks Inc 36.35M
NovaBay Pharmaceuticals Inc 0.004M